What Is the Purpose of Diagnostic Tests?

 

Diagnostic tests are used to find out whether you have cancer. But they are also used for many other purposes, including to:  

Find out where the cancer started -- Diagnostic tests are used to locate the part of the body where the cancer started. This is important for choosing the appropriate treatment(s) and predicting what symptoms you are likely to experience.

Identify cancer cell type -- Cancer can involve one of several types of cells in a given part of the body. For example, bladder cancer may start in the transitional cells (cells that change their shape when the bladder tissue is stretched) or squamous cells (cells that line the bladder). Different types of cells grow at different rates and are likely to behave in different ways.

Learn whether the cancer has spread -- Cancer cells can spread from the place where they started to lympth nodes (small organs that help the body fight infection), organs near the place where the tumor started, or other parts of the body.

Predict symptoms and tumor behavior -- Diagnostic test results provide useful information about the symptoms you are likely to experience, whether your cancer is likely to spread, and how quickly it is likely to grow.

Choose appropriate treatment -- Different types of cancer respond differently to different kinds of treatment. By identifying the type of cancer you have, whether it has spread, and other features of the disease, diagnostic tests can help your doctor identify the best treatment for your disease.

Assess treatment effectiveness -- Certain diagnostic tests can be used to find out whether the treatment is shrinking your tumor. They can also show whether you still have cancer cells after you finish treatment.

Keep track of your health -- Once your cancer has been treated successfully, your doctor may order certain diagnostic tests on a regular basis to make sure that the cancer has not come back.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health